With this program, eligible participants may pay as little as $25 for a 1-month supply (4 pens) or 3-month supply (up to 12 pens) [10]
Semaglutide offers a promising new option for chronic weight management when combined with diet and exercise
Of the 39 companies we reviewed, 13% are publicly traded and 44% are venture-backed
doi: 10.3389/fendo.2024.1484838 Received 22 August 2024 Accepted 29 October 2024 Published 14 November 2024 Volume 15 - 2024 Edited by Chao Cheng, Wuxi Peoples Hospital of Nanjing Medical University, China Reviewed by Aimin Jiang, Fudan University, China Jiaheng Xie, Central South University, China Updates Copyright 2024 Hu, Tian, Deng, Wang, Li, Wang, Liu and Li
Its designed for adults who are obese (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol